February 1, 2011

SMAD4-Dependent Barrier Constrains Prostate Cancer Growth and Metastatic Progression

This model-informed progression analysis, together with genetic, functional and translational studies, established SMAD4 as a key regulator of PCA progression in mice and humans. This work led to the development of a clinical test enabling stratification of men with prostate cancer into benign and aggressive groups. Read the Abstract Download the PDF

SMAD4-Dependent Barrier Constrains Prostate Cancer Growth and Metastatic Progression Read More »

Get Insights From Ron

Sign up for the latest news and updates from Ron DePinho, MD